You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid

Showing 6201 - 6225 of 6,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Worldwide (cytarabine, etoposide, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Linz, Austria
  • +54 more
Aug 24, 2012

Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Chronic Myelogenous Leukemia Trial in Houston (Imatinib Mesylate

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Imatinib Mesylate (Gleevec)
  • PTK 787 (vatalanib)
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 19, 2012

Acute Lymphoblastic Leukemia Trial in Salt Lake City (RAPAMYCIN)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Salt Lake City, Utah
    Primary Children's Medical Center
Jul 23, 2013

Brain and CNS Tumors, Extragonadal Germ Cell Tumor, Leukemia Trial in Durham (melphalan)

Completed
  • Brain and Central Nervous System Tumors
  • +4 more
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Feb 15, 2013

Leukemia Trial in United States (alemtuzumab, rituximab, fludarabine phosphate)

Completed
  • Leukemia
  • alemtuzumab
  • +2 more
  • Boston, Massachusetts
  • +4 more
Aug 1, 2013

Collecting Tissue Samples From Leukemia or Other Blood Disorders

Unknown status
  • Leukemia
  • Lymphoma
  • biologic sample preservation procedure
  • Birmingham, Alabama
  • +213 more
Dec 5, 2012

Chronic Lymphocytic Leukemia Trial in Spain (Lenalidomida and Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Lenalidomida and Rituximab
  • Córdoba, Spain
  • +6 more
Sep 27, 2013

Leukemia, Lymphoma Trial in Durham (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • Lymphoma
  • anti-thymocyte globulin
  • +6 more
  • Durham, North Carolina
    Duke Comprehensive Cancer Center
Mar 6, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Columbus (recombinant interferon alfa, recombinant

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • recombinant interferon alfa
  • recombinant interleukin-12
  • Columbus, Ohio
    Arthur G. James Cancer Hospital - Ohio State University
Jan 31, 2013

Leukemia Trial in Hannover (filgrastim, asparaginase, cytarabine)

Unknown status
  • Leukemia
  • filgrastim
  • +11 more
  • Hannover, Germany
    Medizinische Hochschule Hannover
Aug 6, 2013

Leukemia Trial in United Kingdom (rituximab, cyclophosphamide, fludarabine phosphate)

Completed
  • Leukemia
  • rituximab
  • +3 more
  • Birmingham, England, United Kingdom
  • +15 more
Aug 1, 2013

Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Terminated
  • Recurrent Small Lymphocytic Lymphoma
  • +5 more
  • Bendamustine Hydrochloride
  • Alemtuzumab
  • Cleveland, Ohio
  • +1 more
Aug 20, 2013

MALT, Hematopoietic/Lymphoid Cancer, Nodal Marginal Zone B-cell Lymphoma Trial in United States (bortezomib, fludarabine

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +11 more
  • Canton, Ohio
  • +6 more
Sep 27, 2013

Lymphoma, Diffuse Large Cell Trial in St. Louis (Blood draw)

Completed
  • Lymphoma
  • Diffuse Large Cell
  • Blood draw
  • St. Louis, Missouri
    Washington University School of Medicine
May 14, 2013

Metabolic Syndrome in Young Acute Lymphoblastic Leukemia

Completed
  • Leukemia
  • laboratory biomarker analysis
  • +4 more
  • Nashville, Tennessee
  • +1 more
Jun 11, 2013

Leukemia Trial in Canterbury, Leeds (biological, genetic, other)

Completed
  • Leukemia
  • alemtuzumab
  • +3 more
  • Canterbury, England, United Kingdom
  • +1 more
Aug 9, 2013

Non-Hodgkin's Lymphoma or Hodgkin's Disease, Acute Leukaemia, Myelodysplastic Syndrome Trial in Würzburg (Palifermin, Placebo)

Withdrawn
  • Non-Hodgkin's Lymphoma or Hodgkin's Disease
  • +4 more
  • Würzburg, Germany
    Dr Ruth Seggewiss
May 9, 2012

Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in New York (St. John's wort)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • St. John's wort
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 17, 2013

Myelofibrosis Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))

Completed
  • Myelofibrosis
  • Obatoclax mesylate (GX15-070MS)
  • Washington, District of Columbia
  • +6 more
Aug 16, 2013

Metabolic Syndrome in Adolescent and Young Adult Survivors of

Completed
  • Cardiovascular Complications
  • +3 more
    • Seattle, Washington
      Clinical Research Center - Seattle Children's Hospital
    Nov 29, 2012

    Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)

    Completed
    • Leukemia
    • Campath
    • +3 more
    • Rouen, France
      Centre Henri Becquerel
    Jul 24, 2013

    Solid Tumors, Chronic Lymphocytic Leukemia, T-cell-prolymphocytic Leukemia Trial (MK-4827)

    Completed
    • Solid Tumors
    • +2 more
    • (no location specified)
    Jul 23, 2013

    Anemia Trial (Darbepoetin alfa and Epoetin alfa)

    Completed
    • Anemia
    • Darbepoetin alfa and Epoetin alfa
    • (no location specified)
    May 13, 2013

    Leukemia Trial in United States (nelarabine)

    Completed
    • Leukemia
    • Birmingham, Alabama
    • +21 more
    Jul 17, 2013

    Noncontiguous Stage II Small Lymphocytic Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia

    Completed
    • Noncontiguous Stage II Small Lymphocytic Lymphoma
    • +4 more
    • apolizumab
    • +2 more
    • La Jolla, California
    • +1 more
    Jul 15, 2013